Skip to Main Content

Paper Details

Real-world use of nirmatrelvir-ritonavir: who benefits?
Lancet Infect Dis
1
2023
Author NameAffiliation
Adit A GindeColorado University School of Medicine
  • 1 - 1

Datasets

Release 1.2